This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Cleveland Clinic Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thaddeus Stappenbeck and His Patent on PAI-1 Inhibitors.
Introduction
Thaddeus Stappenbeck is an inventor associated with Cleveland, Ohio, and The Cleveland Clinic Foundation. His patent work includes research into compounds that inhibit plasminogen activator inhibitor-1 (PAI-1), with potential applications in treating inflammatory bowel diseases (IBDs).
Latest Patents
Stappenbeck is credited with 1 patent: “PAI-1 Inhibitors and Uses Thereof.” The patent describes compounds and pharmaceutical compositions containing them, methods for inhibiting PAI-1, and methods for treating IBDs using the compounds.
Career Highlights
Stappenbeck’s listed invention connects pharmaceutical research with potential therapeutic approaches to IBDs. The patent identifies The Cleveland Clinic Foundation as his affiliated organization.
Collaborations
Vara Prasad Josyula is identified as Stappenbeck’s coworker.
Conclusion
Thaddeus Stappenbeck’s patent on PAI-1 inhibitors reflects research into compounds and treatment methods with potential relevance to inflammatory bowel diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile